Detalhe da pesquisa
1.
Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.
Invest New Drugs
; 34(1): 96-103, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26581401
2.
5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial.
Cancer
; 121(15): 2537-43, 2015 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25930719
3.
North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.
Menopause
; 22(6): 627-32, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25423327